My Cart [ 0 ]
Home > Antibodies > Anti-Mouse Antibodies (In Vivo) > Anti-Mouse CD54 (ICAM-1) Monoclonal Antibodies

Anti-Mouse CD54 (ICAM-1) Monoclonal Antibodies

ICAM-1, Ly-47

Catalog No. Product Name Size List Price (US$) Quantity
PA007551.r2b In Vivo Grade Recombinant Anti-mouse CD54 (ICAM-1) Monoclonal Antibody (Clone: YN1/1.7.4), Rat IgG2b Kappa 1 mg 150.00
PA007551.r2b In Vivo Grade Recombinant Anti-mouse CD54 (ICAM-1) Monoclonal Antibody (Clone: YN1/1.7.4), Rat IgG2b Kappa 5 mg 350.00
PA007551.r2b In Vivo Grade Recombinant Anti-mouse CD54 (ICAM-1) Monoclonal Antibody (Clone: YN1/1.7.4), Rat IgG2b Kappa 25 mg 900.00
Description

PA007551.r2b: In Vivo Grade Recombinant Anti-mouse CD54 (ICAM-1) Monoclonal Antibody (Clone: YN1/1.7.4), Rat IgG2b Kappa

Recombinant Rat IgG2b Monoclonal Antibody.
Clone: YN1/1.7.4.
Isotype: Rat IgG2b kappa.
Source: The anti-mouse CD54 (ICAM-1) monoclonal antibody (clone: YN1/1.7.4) was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant rat monoclonal antibody (clone: YN1/1.7.4) specifically binds to mouse CD54 (ICAM-1) .
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD54 (ICAM-1) protein.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The in vivo grade recombinant anti-mouse CD54 (ICAM-1) monoclonal antibody of clone YN1/1.7.4 is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

References of Anti-mouse CD54 (ICAM-1) Monoclonal Antibody:

PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions.
Thomas, S. Y., et al. J Exp Med. 2011 Jun 6;208(6):1179-88. doi: 10.1084/jem.20102630. PMID: 21624939
Injection of blocking antibodies against LFA-1 and ICAM-1 induced the rapid release of liver NKT cells into the peripheral blood, demonstrating the critical role of these integrins in the long-term intravascular residence of NKT cells. ...Blocking antibodies against mouse CD11a (LFA-1; M17/4), CD54 (ICAM-1; YNI.7.4), CD49d (VLA-4; PS/2), and CD106 (VCAM-1; M/K-2.7) and rat IgG2a Control (2A3) were purchased from BioXCell and injected iv 3 h before tissue harvest. ...Within 3 h, we observed a fivefold drop on average in the NKT cell numbers recovered from the liver. ...This massive drop was accompanied by a 10-fold increase of the frequency of NKT cell in the peripheral recirculating blood, which now exceeded that of lymphoid tissues. ...In contrast, blocking with anti?VLA-4 and anti?VCAM-1, which play a substantial role in the intraluminal crawling and transmigration of conventional effector T cells, had no effect.
Tags: anti-mouse CD54 (ICAM-1) YN1/1.7.4; anti-mouse CD54 (ICAM-1) YN1/1.7.4 mAb

Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells.
Kish, D. D., et al. J Immunol. 2011 Feb 15;186(4):2117-26. doi: 10.4049/jimmunol.1002337. PMID: 21239709
Contact hypersensitivity is a CD8 T cell-mediated response to hapten sensitization and challenge of the skin. ...Effector CD8 T cell recruitment into the skin parenchyma to elicit the response to hapten challenge requires prior CXCL1/KC-directed neutrophil infiltration within 3?6 h after challenge and is dependent on IFN-? and IL-17 produced by the hapten-primed CD8 T cells. ...Mechanisms directing hapten-primed CD8 T cell localization and activation in the Ag challenge site to induce this early CXCL1 production in response to 2,4-dinitrofluorobenzene were investigated. ...Both TNF-? and IL-17, but not IFN-?, mRNA was detectable within 1 h of hapten challenge of sensitized mice and increased thereafter.These results indicate that hapten application to the skin of sensitized animals initiates an inflammatory response promoting hapten-primed CD8 T cell localization to the challenge site through TNF-??induced ICAM-1 expression and CD8 T cell activation to produce IFN-? and IL-17 through endothelial cell presentation of hapten.
Tags: anti-mouse CD54 (ICAM-1) YN1/1.7.4 in vivo; anti-mouse CD54 (ICAM-1) YN1/1.7.4 in animal model

Effects of ICAM-1 antisense oligonucleotide on the tubulointerstitium in mice with unilateral ureteral obstruction.
Cheng, Q. L., et al. Kidney Int. 2000 Jan;57(1):183-90. doi: 10.1046/j.1523-1755.2000.00825.x. PMID: 10620199
Four micrometer cryosections were incubated with 5 ?g/mL of rat antimouse ICAM-1 monoclonal antibody YN1/1.7.4, with 15 ?g/mL of Mac-1 antibody (Pharmingen, San Diego, CA, USA). ...The ICAM-1 expression on the TEC surface was determined by immunocytochemical staining. ICAM-1 monoclonal antibody YN1/1,7,4 (1 ?g/mL) was a gift from Dr. Matsuda (Juntendo University, Tokyo, Japan). ...Group A was treated with ICAM-1 ASON, which was injected intravenously at the dosage of 1 mg/kg/day every other day for one week. ...After being prehybridized, the blots were hybridized with mouse ICAM-1 cDNA probe labeled with [?-32P]dCTP using random primed DNA labeling kit (Boehringer Mannheim, Germany) at 65°C for 24 hours. Autoradiography was performed at -70°C using intensifying screens. ...To obtain information about the distribution of ICAM-1 ASON in mice, we injected the FITC-labeled ICAM-1 ASON via tail vein at 10 mg/kg into either normal mice or mice with UUO operation for 16 hours.
Tags: anti-mouse CD54 (ICAM-1) YN1/1.7.4 antibody in cancer research; anti-mouse CD54 (ICAM-1) YN1/1.7.4 in mouse tumor model

For more references about Anti-mouse CD54 (ICAM-1) Monoclonal Antibody please contact our scientific support team with message@sydlabs.com.

Related Links

See our Privacy Policy